Shares in Insulet (NSDQ:PODD) soared today after the medical device maker topped sales expectations on Wall Street with its third quarter results. The Billerica, Mass-based company posted a net loss of -$2.2 million on sales of $121.8 million for the 3 months ended Sept. 30, for bottom-line growth of 38% on sales growth of 28% compared with […]
MassDevice Earnings Roundup
Smith & Nephew takes $5m hit from hurricanes
Smith & Nephew (NYSE:SNN) said today that it took a $5 million hit during the third quarter from the hurricanes that devastated Texas and Puerto Rico and guided toward the low end of its outlook for the rest of the year. The British orthopedics and wound care giant, which only reports profit numbers at the […]
RTI Surgical shares rise on Q3 beat
Shares in RTI Surgical (NSDQ:RTIX) rose today after the medical device maker met expectations on Wall Street with its 3rd quarter earnings results. The Alachua, Fla.-based company posted profits of $16.6 million, or 23¢ per share, on sales of $66.7 million for the 3 months ended September 30, seeing a massive swing from the red on the […]
Dexcom beats earnings estimate by 12 cents in Q3
Shares in Dexcom (NSDQ:DXCM) soared today after the medical device maker topped expectations on Wall Street with its third quarter results. The San Diego, Calif.-based company posted a net loss of -$2 million, or -2¢ per share, on sales of $184.6 million for the 3 months ended Sept. 30, for sales growth of 24% compared with the […]
Wright Medical shares tumble on Q3 sales miss, growing losses
Shares in Wright Medical (NSDQ:WMGI) fell today after the medical device maker missed sales expectations on Wall Street with its 3rd quarter earnings results. The Netherlands-based company posted losses of $131.9 million, or $1.26 per share, on sales of $170.5 million for the 3 months ended September 30, seeing losses grow 19.7% while sales grew a […]
Fresenius shares fall on Q3 sales miss
Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) have fallen slightly today after the dialysis-focused medical device company missed sales expectations on Wall Street with its 3rd quarter earnings results, despite topping EPS results. The Bad Homburg, Germany-based company posted profits of $359.9 million, or $1.18 per share, on sales of $5.1 billion for the 3 months […]
Grifols posts Q3 sales, earnings gains
Grifols (NSDQ:GRFS) today reported third-quarter sales and earnings growth that nevertheless missed the consensus forecast The Spanish healthcare giant posted profits of €153.9 million , or €0.22 per share, on sales of €1.06 billion for the three months ended Sept. 30 (about $179.3 million, 23¢ and $1.23 billion, respectively). Analysts on Wall Street were looking for earnings of 30¢ […]
K2M Holdings beats on Q3 earnings, misses on sales
K2M (NSDQ:KTWO) yesterday topped the earnings consensus for its third-quarter but missed expectations for sales and lowered its earnings outlook for the rest of the year. The Leesburg, Va.-based orthopedics company posted losses of -$8.5 million, or -20¢ per share, on sales of $62.7 million for the three months ended Sept. 30, widening its losses by […]
LivaNova swings to Q3 black
LivaNova (NSDQ:LIVN) today swung to profitability during the third quarter and raised its earnings outlook for the rest of 2017, after handily beating the consensus forecast on Wall Street. The London-based medical device company reported profits of $27.8 million, or 57¢ per share, on sales of $309.7 million for the three months ended Sept. 30, compared […]
Teleflex tops forecasts with Q3 results
Teleflex (NYSE:TFX) today reported third-quarter sales and earnings that topped the consensus outlook on Wall Street and raised its forecast for the rest of the year. The Wayne, Pa.-based medical device company posted profits of $77.0 million, or $1.65 per share, on sales of $534.7 million for the three months ended Oct. 1, for a bottom-line […]
Becton, Dickinson beats The Street with Q4, 2017 numbers
Becton Dickinson (NYSE:BDX) today beat the consensus Wall Street forecast for both its fiscal fourth-quarter and full-year results as it prepares to close its blockbuster $24 billion merger with C.R. Bard (NYSE:BCR). Franklin Lakes, N.J.-based BD posted profits of $289 million, or $1.24 per share, on sales of $3.17 billion for the three months ended Sept. […]